Pfizer-Valneva Lyme disease shot shows more than 70% efficacy
23 Mar 2026 //
REUTERS
Pfizer to discontinue low-dose ATTR drug Vyndaqel in US in 2025
29 Aug 2025 //
FIERCE PHARMA
US FDA approves Pfizer`s drug for rare bleeding disorder
14 Oct 2024 //
REUTERS
US CDC alerts healthcare providers of increase in meningococcal disease
29 Mar 2024 //
REUTERS
AstraZeneca to buy Pfizer`s rare disease gene therapy portfolio for up to $1 bln
28 Jul 2023 //
PRESS RELEASE
Pfizer to boost R&D spend in ’23 despite rare disease rethink
31 Jan 2023 //
FIERCE BIOTECH
Pfizer to scale down early-stage rare disease research
07 Jan 2023 //
REUTERS
Treatment for rare, paediatric growth hormone deficiency recommended by NICE
23 Dec 2022 //
PHARMAFILE
Pfizer sets up refund program for rare disease drug Panzyga
10 Aug 2022 //
FIERCEPHARMA
Pfizer launches rebate program for rare disease patients
10 Aug 2022 //
ENDPOINTS NEWS
Pfizer’s rare disease plan takes surprising hit
25 Jan 2022 //
FIERCEPHARMA
Spero Announces $40M Equity Investment from Pfizer Inc.
30 Jun 2021 //
GLOBENEWSWIRE
Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod
09 Jun 2021 //
BUSINESSWIRE
Suspicions grow that nanoparticles in Pfizer’s COVID-19 trigger rare allergic
21 Dec 2020 //
SCIENCEMAG
Alnylam scores speedy FDA approval for rare liver disease
21 Nov 2019 //
FIERCE PHARMA
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
13 Sep 2019 //
RAPS
Rare Disease R&D Investments Likely To Grow In Biopharma
24 Apr 2019 //
FORBES
Uniqure turns the screw on Spark and Pfizer
09 Feb 2019 //
EVALUATE
Intellia`s gene-editing ATTR treatment cuts abnormal proteins in monkeys
18 Oct 2018 //
FIERCE BIOTECH
Alnylam Pharmaceuticals Could Use Some Straightforward Good News
27 Sep 2018 //
SEEKING ALPHA
Pfizer`s drug for rare heart disease gets a boost
27 Aug 2018 //
BUSINESS TIMES
Biotech small-cap looks to rival Pfizer with rare disease drug
07 Aug 2018 //
MONEYWEB
Pfizer drug gets speedy FDA review for rare heart failure complication
24 May 2018 //
PMLIVE
Alnylam Falls on Pfizer`s Rare Disease Drug Success
02 Apr 2018 //
NASDAQ
Pfizer`s rare heart disease drug succeeded in a late-stage study
29 Mar 2018 //
CNBC
Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ
23 Jan 2018 //
PMLIVE
Exact therapy for rare genetic disorders of obesity
11 Jan 2018 //
BIOSPECTRUM
Pfizer, NEA back Cydan II’s plans to launch a fresh slate of biotech startups
17 Oct 2017 //
ENDPTS
EU drugs head fears delays, health hazards as agency uprooted
03 Oct 2017 //
REUTERS
Pfizer Spins Off New Company to Develop Some Rare Disease Drugs
26 Sep 2017 //
BLOOMBERG
FDA approves Pfizer`s drug for rare blood cancer
18 Aug 2017 //
CNBC
Pfizer drug gets fast review in rare heart condition
10 Jun 2017 //
Six new medicines backed for EU approval
28 Mar 2017 //
PHARMA TIMES
Pfizer looks at building major gene therapy manufacturing facility in North Carolina
09 Mar 2017 //
FIERCE PHARMA
PhaseRX, Gemphire move forward with IPOs despite challenging market
20 Apr 2016 //
BIOPHARMA DIVE
Pfizer, HemoShear collaboration to create new `safety paradigm`
13 Jan 2016 //
OUTSOURCING PHARMA

Market Place
Sourcing Support